The Approval Process in Action

Source: The Life Sciences Report and Visual Capitalist  (5/1/13)

What catalysts in the drug development process move biotech company stocks? The savvy investor must know what steps in the U.S. Food and Drug Administration's approval process can propel a stock up or down. From drug discovery to the much-anticipated PDUFA date, The Life Sciences Report and the Visual Capitalist have collaborated on an infographic that describes both the process and related catalysts.


For news on how catalysts affect specific stocks, read the updated Life Sciences Report Watchlist.

Related Articles

Biotech Watchlist 2016